Search - tctmd.com

Displaying 21 - 40 of 57

Sort: Relevancy | Date

Presentation TCT 2017

South Africa Presents a Case: STEMI With Multivessel Disease

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Riaz S Dawood

October 30, 2017

Presentation TCT 2017

Italy Presents a Case: STEMI Due to Left Main Disease

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Ugo Limbruno

October 30, 2017

Presentation TCT 2017

Israel Presents a Case: Giant Thrombus in a STEMI Patient

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Eli I. Lev

October 30, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Asymptomatic Carotid Artery Stenosis: When to Screen and When to Intervene

Todd Neale

October 05, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Shelley Wood

August 15, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

News Daily News

Real-World TEVAR Population Shows Female Sex Independently Predictive of Mortality

L.A. McKeown

July 04, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Featured Fellow

Ankur Kalra, MD

Yael L. Maxwell

May 26, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After ACS Saves Money, Prevents Bleeding

News Conference News EuroPCR 2017

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS

Yael L. Maxwell

May 16, 2017

Advertisement

South Africa Presents a Case: STEMI With Multivessel Disease

Italy Presents a Case: STEMI Due to Left Main Disease

Israel Presents a Case: Giant Thrombus in a STEMI Patient

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Asymptomatic Carotid Artery Stenosis: When to Screen and When to Intervene

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Valve Deterioration and Durability Definitions Now Standardized in New Guide

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Real-World TEVAR Population Shows Female Sex Independently Predictive of Mortality

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Ankur Kalra, MD

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content